TY - JOUR T1 - Projecting the second outbreaks for global COVID-19 pandemic JF - medRxiv DO - 10.1101/2020.07.15.20154161 SP - 2020.07.15.20154161 AU - Jianping Huang AU - Xiaoyue Liu AU - Li Zhang AU - Kehu Yang AU - Yaolong Chen AU - Zhongwei Huang AU - Chuwei Liu AU - Xinbo Lian AU - Danfeng Wang Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/16/2020.07.15.20154161.abstract N2 - COVID-19 is now in an epidemic phase, with a second outbreak likely to appear at any time. The intensity and timing of a second outbreak is a common concern worldwide. In this study, we made scenario projections of the potential second outbreak of COVID-19 using a statistical-epidemiology model, which considers both the impact of seasonal changes in meteorological elements and human social behaviors such as protests and city unblocking. Recent street protests in the United States and other countries are identified as a hidden trigger and amplifier of the second outbreak. The scale and intensity of subsequent COVID-19 outbreaks in the U.S. cities where the epidemic is under initial control are projected to be much greater than those of the first outbreak. For countries without reported protests, lifting the COVID-19 related restrictions prematurely would accelerate the spread of the disease and place mounting pressure on the local medical system that is already overloaded. We anticipate these projections will support public health planning and policymaking by governments and international organizations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was jointly supported by the National Science Foundation of China (41521004) and the Gansu Provincial Special Fund Project for Guiding Scientific and Technological Innovation and Development (Grant No. 2019ZX-06).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Lanzhou UninversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data in this paper are publicly available at http://covid-19.lzu.edu.cn/. http://covid-19.lzu.edu.cn/ ER -